相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity
Herbert J. Zeh et al.
MOLECULAR THERAPY (2015)
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
Oncolytic Viruses and Their Application to Cancer Immunotherapy
E. Antonio Chiocca et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Trial Watch Oncolytic viruses for cancer therapy
Jonathan Pol et al.
ONCOIMMUNOLOGY (2014)
Going viral with cancer immunotherapy
Brian D. Lichty et al.
NATURE REVIEWS CANCER (2014)
Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells
Jean-Baptiste Guillerme et al.
CLINICAL CANCER RESEARCH (2013)
Measles virus causes immunogenic cell death in human melanoma
O. G. Donnelly et al.
GENE THERAPY (2013)
Deciphering and Reversing Tumor Immune Suppression
Greg T. Motz et al.
IMMUNITY (2013)
Local Administration of TLR Ligands Rescues the Function of Tumor-Infiltrating CD8 T Cells and Enhances the Antitumor Effect of Lentivector Immunization
Haiyan Xiao et al.
JOURNAL OF IMMUNOLOGY (2013)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis
Pragatheeshwar Thirunavukarasu et al.
MOLECULAR THERAPY (2013)
Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells
Lynsey M. Whilding et al.
MOLECULAR THERAPY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
Jean-Francois Fonteneau et al.
ONCOIMMUNOLOGY (2013)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Oncolytic Virus and Anti-4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
Liza B. John et al.
CANCER RESEARCH (2012)
The Next Challenge in Cancer Immunotherapy: Controlling T-Cell Traffic to the Tumor
Jean-Pierre Abastado
CANCER RESEARCH (2012)
Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
Iulia Diaconu et al.
CANCER RESEARCH (2012)
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Melody A. Swartz et al.
CANCER RESEARCH (2012)
Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
Shohei Miyamoto et al.
CANCER RESEARCH (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
Jun Li et al.
MOLECULAR THERAPY (2011)
Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma
Bita Boozari et al.
GUT (2010)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors
Pawel Kalinski et al.
SEMINARS IN IMMUNOLOGY (2010)
What's the place of immunotherapy in malignant mesothelioma treatments?
Marc Gregoire
CELL ADHESION & MIGRATION (2010)
CCL5-Mediated Endogenous Antitumor Immunity Elicited by Adoptively Transferred Lymphocytes and Dendritic Cell Depletion
Yolanda Nesbeth et al.
CANCER RESEARCH (2009)
Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
Candice L. Willmon et al.
CANCER RESEARCH (2009)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
Tumour immunity: effector response to tumour and role of the microenvironment
Alberto Mantovani et al.
LANCET (2008)
Orchestrating the orchestrators: chemokines in control of T cell traffic
Shannon K. Bromley et al.
NATURE IMMUNOLOGY (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Failure at the effector phase: Immune barriers at the level of the melanoma tumor microenvironment
Thomas F. Gajewski
CLINICAL CANCER RESEARCH (2007)
Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture
Klara Berencsi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2
ZS Guo et al.
CANCER RESEARCH (2005)
The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis
PJ Hensbergen et al.
JOURNAL OF IMMUNOTHERAPY (2005)
A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo
NHR Hamilton et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Virally induced lytic cell death elicits the release of immunogenic GRP94/gp96
B Berwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
